New strategies in gene therapy are integrating multiple modern techniques to take on contemporary challenging diseases, such as solid-tumor cancers. Dr. Eric Ostertag of Poseida Therapeutics describes their transposon-based gene therapies that deliver useful gene replacements through biodegradable, tissue-targeted nanoparticles. This contrasts against the older gene therapy technologies that relied on viral delivery.  In addition, Poseida offers new approaches in CAR-T cell therapies, genetic adjustment of native immune cells to target cancers. These One-time treatments appear to be promising in treating a variety of cancers using innovative strategies.Posieda Therapeutics Website # COLABRATalking Biotech is brought to you by Colabra – an R&D platform that brings your lab’s world-changing research together in one shared space. Learn more at https://www.colabra.app/# TALKING BIOTECHTwitter: https://twitter.com/talkingbiotechWebsite: https://www.colabra.app/podcasts/talking-biotech/Instagram: https://www.instagram.com/colabrahqThe Talking Biotech podcast is distinct from Dr. Kevin Folta's teaching and research roles at the University of Florida. The views expressed on the show are those of Dr. Folta and his guests, and do not reflect the opinions of the university or Colabra.